[go: up one dir, main page]

AU2966795A - Optically active isomers of dihydrexidine and its substituted analogs - Google Patents

Optically active isomers of dihydrexidine and its substituted analogs

Info

Publication number
AU2966795A
AU2966795A AU29667/95A AU2966795A AU2966795A AU 2966795 A AU2966795 A AU 2966795A AU 29667/95 A AU29667/95 A AU 29667/95A AU 2966795 A AU2966795 A AU 2966795A AU 2966795 A AU2966795 A AU 2966795A
Authority
AU
Australia
Prior art keywords
phenanthridine
hexahydrobenzo
compound
dihydroxy
arh
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU29667/95A
Other languages
English (en)
Inventor
Richard B Mailman
David E Nichols
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of North Carolina at Chapel Hill
Purdue Research Foundation
Original Assignee
University of North Carolina at Chapel Hill
Purdue Research Foundation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of North Carolina at Chapel Hill, Purdue Research Foundation filed Critical University of North Carolina at Chapel Hill
Publication of AU2966795A publication Critical patent/AU2966795A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
    • C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
    • C07D221/04—Ortho- or peri-condensed ring systems
    • C07D221/18—Ring systems of four or more rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
AU29667/95A 1994-07-15 1995-07-10 Optically active isomers of dihydrexidine and its substituted analogs Abandoned AU2966795A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US27534294A 1994-07-15 1994-07-15
US275342 1994-07-15
PCT/US1995/008598 WO1996002513A1 (fr) 1994-07-15 1995-07-10 Isomeres optiquement actifs de la dihydrexidine et de ses analogues substitues

Publications (1)

Publication Number Publication Date
AU2966795A true AU2966795A (en) 1996-02-16

Family

ID=23051882

Family Applications (1)

Application Number Title Priority Date Filing Date
AU29667/95A Abandoned AU2966795A (en) 1994-07-15 1995-07-10 Optically active isomers of dihydrexidine and its substituted analogs

Country Status (7)

Country Link
EP (1) EP0773933A1 (fr)
JP (1) JPH10502923A (fr)
AU (1) AU2966795A (fr)
CA (1) CA2195239A1 (fr)
IL (1) IL114608A0 (fr)
WO (1) WO1996002513A1 (fr)
ZA (1) ZA955931B (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10111486A1 (de) * 2001-03-09 2002-10-02 Ralph R Dawirs Verwendung einer oder mehrerer neuroaktiver Substanzen zur Behandlung der Parkinsonschen Krankheit
WO2003013532A1 (fr) * 2001-08-10 2003-02-20 Purdue Research Foundation Dinapsoline chirale
US7220754B2 (en) 2002-02-15 2007-05-22 Darpharma, Inc. Mono-ester and asymmetrically substatuted di-ester pro-drugs of dopamide D1 receptor agonists
EP2364317B1 (fr) * 2008-08-05 2015-07-29 Effipharma, Inc. Ligands de récepteur de dopamine à durée d'action prolongée
WO2021021953A2 (fr) 2019-07-30 2021-02-04 Sanford Burnham Prebys Medical Discovery Institute Agonistes du récepteur d1 de la dopamine et leurs méthodes d'utilisation

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5047536A (en) * 1989-03-17 1991-09-10 Purdue Research Foundation Hexahydrobenzo(A)phenanthridine compounds
IE912999A1 (en) * 1990-09-07 1992-03-11 Abbott Lab Phenanthridine compounds
WO1993024462A1 (fr) * 1992-05-26 1993-12-09 Purdue Research Foundation Hexahydrobenzo[a]phenanthridines substituees

Also Published As

Publication number Publication date
EP0773933A1 (fr) 1997-05-21
ZA955931B (en) 1996-01-26
IL114608A0 (en) 1995-11-27
CA2195239A1 (fr) 1996-02-01
JPH10502923A (ja) 1998-03-17
WO1996002513A1 (fr) 1996-02-01

Similar Documents

Publication Publication Date Title
JP5802792B2 (ja) パーキンソン病の治療のために有用なカテコールアミン誘導体
WO2009002873A1 (fr) Composés, compositions et procédés pour réduire des niveaux de lipide
Knoerzer et al. Dopaminergic benzo [a] phenanthridines: resolution and pharmacological evaluation of the enantiomers of dihydrexidine, the full efficacy D1 dopamine receptor agonist
ZA200508860B (en) Positive modulators of nicotinic acetylcholine receptors
JP2014511883A (ja) ２−オキソ−１−イミダゾリジニルイミダゾチアジアゾール誘導体
US20220387403A1 (en) Compounds, compositions and methods for treating nash, nafld, and obesity
US5959110A (en) Fused isoquinolines as dopamine receptor ligands
AU2966795A (en) Optically active isomers of dihydrexidine and its substituted analogs
US6133258A (en) Inhibitor of kainic acid neurotoxicity and pyridothiazine derivative
EP1023269A1 (fr) Agonistes de beta3-adrenorecepteurs, compositions d'agonistes et procedes d'utilisation
EP2848617B1 (fr) Composé diaryl[a, g]quinolizidine, son procédé de préparation, composition pharmaceutique, et leurs utilisations
US8318938B2 (en) Trans-fused chromenoisoquinolines synthesis and methods for use
JP2000511917A (ja) 三環式アミン誘導体
AU684730B2 (en) Octahydrobenzo{f}quinoline-based receptor agonists and antagonists
AU777522B2 (en) Chromeno(4,3,2-de)isoquinolines as potent dopamine receptor ligands
NZ221485A (en) Hexahydroarylquinolizine derivatives and pharmaceutical compositions
EP0713484A1 (fr) Inhibiteurs des transporteurs d'amine biogenes
BR112020005992A2 (pt) novos sais
US5863928A (en) Octahydrobenzo f!quinoline-based receptor agonists and antagonists
CA2146000A1 (fr) Derives de substitution en 3,3 d'indolin-2-ones tri- et tetracycliques, utiles pour le traitement de troubles cognitifs
Robaa Novel Benzindoloazecines and Dibenzazecines: Synthesis and Affinities for the Dopamine Receptors